Multiple sclerosis (MS) is an inflammatory and demyelinating disease of the central nervous system (CNS). Mesenchymal stem cells (MSC) have been shown to ameliorate symptoms in experimental autoimmune encephalomyelitis (EAE), a model of MS. Using cloned MSC labeled with clinically approved small particles of iron oxide (SPIO) for treatment of EAE we analyzed the tissue localization of transferred cells. Treatment with unlabeled MSC led to disease amelioration compared to controls. In contrast, treatment with SPIOlabeled MSC lead to increase in disease severity. Treatment with SPIO alone did not alter disease course. After transplantation labeled and nonlabeled MSC were detected in the CNS and the liver with significantly more SPIO-labeled cells present in the CNS. Iron deposition was present in the group treated with SPIOlabeled MSC, indicating that in vivo the initially cell surface-bound iron detached from the MSC. These results could be of great importance for imaging of patients in the clinical setting, indicating that in vivo application of SPIO-labeled MSC needs to be performed with caution because the cell-derived exposure of iron can lead to disease aggravation.
INTRODUCTION
MOG EAE in DA rats is a very good tool to assess the therapeutic benefit of stem cells of various origins as well as new imaging modalities that have to be devel-Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of the central nervous system oped in order to optimize treatment monitoring (14, 52) . Most attention has been given to neural stem cells in (CNS) that results in disability (37) . So far the treatment options are limited. Stem cells of various origins have EAE (3, 10, 41, 42) . Intravenous application of neural stem cells in mice leads to their settlement in small ves-been introduced into experimental models of MS (29, 34) . Experimental autoimmune encephalomyelitis (EAE) sels in the CNS. In such niches they stay in an undifferentiated state, inducing an immune deviation and disease induced in DA rats by myelin-oligodendrocyte-glycoprotein (MOG) is a good model of MS, because it repro-amelioration by multiple mechanisms. Similar observations have been made for mesenchymal stem cells duces parts of the disease course with a relapsing-remitting type of disease resulting in inflammatory and (MSC) in mice (12, 60) . In contrast to the IV route of stem cell application, direct injection of stem cells into demyelinating lesions in the CNS (29, 49, 57) . Therefore, 924 SCHÄ FER ET AL. the CNS can potentially lead to improved tissue repair MATERIALS AND METHODS (6) . Keeping in mind the enormous potential of stem cell Rats therapy, it is necessary to develop noninvasive, yet Female DA rats 8 weeks of age were used in all exhighly sensitive, diagnostic tools (8, 53) . The major imperiments. DA/OlaHsd rats were bought from Harlan aging modalities for that purpose might be positron Winkelmann (Borchen, Germany) and were kept under emission tomography (PET), optical imaging (OI), and specific pathogen-free (SPF) conditions. The experimagnetic resonance imaging (MRI), all of them with ments were approved by the institutional animal care strengths and weaknesses.
committee of the University of Tübingen. Limitations of PET include the poor spatial resolution (31), the radiation of the tracers that results in cell dam-Synthetic Peptides and Antigens age, and the short half life time of the tracers used (e.g.
MOG 73-90 (KESIGEGKVALRIQNVRF), MOG F-18, T 1/2 110 min). OI also is a very sensitive method, 91-108 (SDEGGYTCFFRDHSYQEE), and myelin basic which is widely accepted in small-animal studies protein (MBP) 63-88 (HTRTTHYGSLPQKSQRTQDE (mouse, rat) (33) . However, due to the limited tissue NPVVHF) were prepared by Karl-Heinz Wiesmüller penetration of the light emitted from the fluorochromes (EMC microcollections, Tübingen, Germany) by solid used, the use of OI is limited to superficial processes.
phase peptide synthesis using F-moc/tBu chemistry. Another problem is the quantification of the signal.
Peptides were purified by preparative high-performance High-field MRI (≥1.5 Tesla) in combination with special liquid chromatography (HPLC) (Abimed, Langenfeld, high-resolution receiver coils and innovative signal am-Germany). The identity of the purified peptides was conplification strategies might be a compromise for clinical firmed by electrospray mass spectrometry. The purity of purposes. However, the sensitivity of MRI compared to peptides was more than 95% as determined by analytical PET is lower by the factor 10 2 to 10 5 depending on the HPLC (Abimed). Recombinant rat MOG, corresponding structures examined. On the other hand, MRI offers a to the N-terminal sequence of MOG (amino acids 1superb spatial resolution (300 µm can be easily achieved 125, MOG 1-125) was expressed in Escherichia coli compared to 5-10 mm using PET). Other advantages of and purified. The purified protein in 6 M urea was dia-MRI are the lack of radiation exposure and the fact that lyzed against phosphate-buffered saline (PBS) and patient size does not limit the examination. Furthermore, stored at −20°C. long-term studies over a period of 6 weeks already have Enzyme-Linked Immunospot (ELISPOT) been performed successfully (4).
There are two possible strategies to label cells for Nitrocellulose-bottomed 96-well plates (MAHA; Milli-MRI: labeling with paramagnetic substances like gadopore, Molsheim, France) were coated overnight at 4°C linium (Gd) DTPA (11, 15, 36) or with superparamagwith anti-interferon-γ (anti-IFN-γ) mouse monoclonal netic substances (small/ultrasmall particles of iron oxantibody (mAb) DB1 (a generous gift from Peter van ide, SPIO/USPIO) (24, 44, 48, 50, 59) . The latter seem to der Meide, TNO Primate Center, Rijswijk, The Netherbe more suitable as iron labeling results in larger susceplands). Plates were washed twice with PBS and blocked tibility artifacts (="signal") and iron is less toxic than with 5% fetal calf serum (FCS) with Dulbecco's modi-Gd. Iron-based contrast agents are already FDA and CE fied Eagle medium (DMEM). MNCs (2 × 10 5 per well) approved (Endorem, Guerbet, Paris, France; Resoin 200 µl complete medium (CM) were added to the vist, Schering AG, Berlin, Germany) and under conplates and incubated for 48 h at 37°C in a humidified sideration for approval (Sinerem, Guerbet); the major atmosphere containing 5% CO 2 . Cells were cultured differences of those particles are size (20-120 nm) and with or without the relevant antigen for 48 h. Concanavcoating.
alin A (conA) was used in a concentration of 1 µg/ml In this report we investigated the therapeutic potential and 2.5 µg/ml. of MSC in MOG EAE in DA rats. We used MSC de-Cells were discarded and plates washed four times rived from bone marrow of DA rats. MSC were cloned with PBS. Secreted and bound IFN-γ was visualized and applied to DA rats. In order to identify "hot spots" with biotinylated DB12 mAb against rat IFN-γ (also a of the interaction of the graft with the host's immune generous gift from Peter van der Meide), avidin-biotinsystem, we labeled the MSC with SPIO prior to IV inperoxidase (Vector Laboratories, Burlingame, CA) and jection. To our surprise, labeling led to an abolishment by staining with carbazole (Sigma (Life Technologies) , 1% glutamine (Life Technologies), and 50 µM 2-mercap-nonadherent cells were removed and the adherent cells were cultured (passage 0). Medium was changed every toethanol (Life Technologies) were cultured with or without the relevant Ag for 48 h and pulsed with 0.5 3 or 4 days. At subconfluence (70%) the cells were detached with Accutase (PAA Laboratories, Cölbe, Ger-mCi [ 3 H]TdR per well for 18 h. ConA (Sigma) was used at a concentration of 1 µg/µl as well as 2.5 µg/ml. Cells many) to start the cloning procedure. Briefly, normal medium was added to the cell suspension to achieve a were harvested and DNA was transferred on glass fiber titers (Skaton, Sterling, VA). Biosciences, Heidelberg, Germany) and cultured (single-Enzyme-Linked Immunosorbent Assay (ELISA) cell cloning, passage 1). After 4 weeks of culture 34 single-cell-derived clones could be identified and trans-At the end of each experiment blood samples for Ab measurements were taken. ELISA plates (96 well; Nunc, ferred to six-well plates (BD Biosciences) (passage 2) and 75-cm 2 culture flasks (Corning Inc.), respectively Roskilde, Denmark) were coated with 2.5 µg/ml (100 µl per well) MOG 1-125 overnight at 4°C. Plates were (passage 3 and higher). One MSC clone for the cell labeling and transplantation experiments was selected ac-washed three times with PBS/0.05% Tween 20 and blocked with 5% milk powder/PBS for 1 h at room tem-cording to the adipogenic and osteogenic differentiation potential and the surface epitope pattern. For this clone perature. Diluted samples were added and plates incubated for 1 h at room temperature. Plates were then additionally chondrogenic differentiation was performed in vitro. The transplantation procedure was performed washed three times and diluted (1:2000) rabbit anti-rat antiserum (Nordic, Tilburg, The Netherlands) was added with clonal MSC at passages 4 and 5. and incubated for 1 h at room temperature. Unbound
In Vitro Differentiation, RT-PCR, and Staining of Cells antibodies were removed by washing the plates and diluted (1:10000) peroxidase-conjugated goat anti-rabbit MSC are functionally characterized by in vitro differentiation assays (40) . We evaluated the adipogenic and antiserum (Nordic) was added and incubated for 30 min. Bound Abs were visualized by 3.3′.5′5′-teramethylben-osteogenic differentiation potential of all 34 clones at passage 3 (P3). One sample of each MSC clone was zidine (TMB) (Sigma Chemical Co.). The enzymatic reaction was stopped with 1 M HCl after 15 min of incu-treated each for 21 days with adipogenic medium and one sample of clonal MSC was treated each for 21 days bation in darkness and the optical density was read at 450 nm. with osteogenic medium as described previously (20, 22) . Two samples of control cells from the each clone Bone Marrow Preparation were cultured with normal medium. After 21 days the cell culture was stained with oil red O for in vitro adipo-Whole bone marrow was taken under sterile conditions from three female DA rats as described previously genesis. At the same passage the osteogenic differentiated cells as well as control cells were cytochemically (17) . After clipping off the ends of the femora and tibiae the whole bone marrow was washed out with PBS (Cam-stained for alkaline phosphatase using a commercial staining kit according to the manufacturer's recommen-brex Bio Sciences, Verviers, Belgium).
dations (Cambrex Bio Science). The chondrogenic dif-MSC Isolation, Cloning, and Cell Culture ferentiation of the selected clone was performed using a commercially available mesenchymal functional differ-To isolate MSC from whole bone marrow we used the density gradient technique as described previously entiation kit (Cat. No. SC006, R&D Systems, Wiesbaden, Germany) at P5. After 14 days the chondrocyte pel-(5). Briefly, 10 ml bone marrow was resuspended in 10 ml PBS (Cambrex Bio Science) and laid over 20 ml let was removed, put on a glass slide, and stained with 1% Alcian Blue 8GX (Serva, Heidelberg, Germany) in Lymphoflot (Biotest AG, Dreieich, Germany). After centrifugation (20 min at 1000 × g without braking) the 3% acetic acid (pH 2.5). Additionally, 8-µm cryosections of the chondrocyte pellets were fixed in ice-cold mononuclear cells were harvested and pooled. The cells were washed twice with PBS, transferred to a 75-cm 2 acetone (Sigma-Aldrich) for 10 min. Cartilage matrix proteoglycans were stained with 0.1% aqueous Safranin culture flask (Corning Inc., Schiphol-Rijk, Netherlands), and incubated (37°C, 5% humidified CO 2 ) with normal O solution for 5 min. Nuclei were counterstained with hemotoxylin before mounting the sections in aqueous medium containing desoxyribonucleotides, ribonucleo-mounting medium (Vector Laboratories). Microscopic probe was ready for analysis. All antibodies were from BD Biosciences. evaluation and digital photographic documentation of the differentiation was performed using Axiovert 200 in-Contrast Media and Cell Labeling verse microscope (Carl Zeiss, Jena, Germany), Axio Cam Icc3 (Carl Zeiss), and AxioVision rel. 4.5 software Resovist (SHU 555A, Schering AG, Berlin, Germany), an MRI contrast agent already approved for clin-(Carl Zeiss).
To evaluate the trilineage differentiation potential of ical use in Europe, Japan, and Australia, is organ specific and used for liver imaging (32, 55, 58) . It consists of the iron-labeled MSC, reverse transcription-polymerase chain reaction (RT-PCR) analysis was performed. Total superparamagnetic iron oxide (SPIO) nanoparticles (4-6 nm) (56) coated with carboxydextran (mean hydrody-ribonucleic acid (RNA) was extracted from adipogenic, osteogenic, and chondrogenic differentiated iron-labeled namic diameter 60 nm), which is accumulated by phagocytosis in Kupffer cells. In order to enhance the labeling MSC (P6) using RNeasy Mini Kit (Quiagen). Reverse transcription was performed by Transcriptor First Strand efficiency and to avoid an impact on the cellular iron metabolism and differentiation potential, a previous de-cDNA Synthesis Kit (Roche), using anchored-oligo (dT) 18 primer. The resulting cDNA was diluted by 1 to scribed SPIO-labeling protocol for rat MSC (47) including the nonliposomal transfection reagent jetPEI TM , a lin-10 and used in the PCR setting. RT-PCR for adipogenic, osteogenic, and chondrogenic marker genes was per-ear polyethylenimine (PolyPlus Transfection, Illkirch, France), was used: Cell labeling of the selected MSC formed using ready-to-use amplification primer mixes for RT-PCR (search-LC) and the LightCycler TM Instru-clone was performed for 4 h with 60 µg/ml Fe in combination with the transfection agent in six-well-plates on ment (Roche).
The expression of the respective genes and the speci-in vitro expanded cells at P4 and P5. After the labeling/ transfection, the cells were washed three times with ficity of the RT-PCR have been shown by gel electrophoresis of the RT-PCR products. The details of the RT-PBS, harvested, and pooled. After performing a total cell count and evaluation of the cell viability, eight probes PCR products are shown in Table 1 .
of labeled and eight probes of unlabeled clonal MSC Flow Cytometry of MSC (containing each 4 × 10 6 cells in each 500 µl PBS) were prepared on ice for immediate cell transplantation. Cells FACS analysis was performed with FACScan (BD not needed for transplantation were cryopreserved for Biosciences) using BD CellQuestPro software with all further experiments (quantification of total iron load, MSC clones at passage 3 and with the selected clonal FACS, electron microscopy). The following abbrevialabeled and unlabeled MSC at passage 6. At subcontions are employed: Resovist = R, jetPEI TM = JP, lafluency (1 × 10 6 cells) the cells were detached with Acbeled cells: JPR-MSC. cutase (PAA Laboratories) and washed (PBS + Accu-Max; PAA Laboratories). Each probe contained a cell Quantification of the Total Iron Load (TIL) of Cells suspension with 5 × 10 5 cells in FACS buffer [PBS + by Photometry 1% bovine serum albumin (Sigma) + 0.1% FCS (Cam-Fe-labeled MSC (1 × 10 5 ) and unlabeled MSC (conbrex Bio Science)]. The FITC-or PE-conjugated antitrol) were thawed and washed three times with PBS. The body (anti-rat CD4, CD8, CD11b, CD29, CD31, CD44, cell pellet was dried for 2 h at 80°C. Then samples were CD45, CD59, CD71, CD73, CD90, CD106, CD117, incubated overnight at room temperature and another 2 CD143, MHC class I, MHC class II) was added. After h at 60°C in perchloric and nitric acid at a 3:1 ratio to an incubation time of 20 min and two washing steps the completely digest the cells and expose iron oxide from the dextran-coated nanoparticles. For photometric determination of the TIL a Ferrozine-based spectrophotomet- Histological Examination (each group n = 8) received either unlabeled MSC (MSC) or JPResovist-labeled MSC (JPR-MSC); con-All rats were sacrificed at day 40 after cell transplantation. The livers and lymph nodes were explanted and trol rats were injected PBS IV. stored in liquid nitrogen. Cryosections of livers and Injection of SPIO Into Rats lymph nodes were screened histologically for iron deposits (Prussian plue staining). The histological detec-To evaluate the effect of SPIO without MSC transplantation on the inflammatory process, we injected IV tion of inflammation and demyelination was performed by Luxol fast blue/periodic acid Schiff (LFB-PAS) on the day of disease induction with rrMOG the same concentration of Resovist (571.5 µg each animal, n = staining of paraformaldehyde-fixed, paraffin-embedded, hemotoxylin and eosin (H&E)-stained sections (5 µm) 6) in which it had been applied in the transplantation setting with JPR-MSC into rats. Control animals (n = 6) of brains and spinal cords. were injected PBS IV.
Homing Experiments Visualization of SPIO-Labeled MSC by MRI MSC (25.2 × 10 6 ) were stained in suspension with PKH26 (Sigma-Aldrich, Taufkirchen, Germany) accord-DA rats were anesthetized by spontaneous inhalation of a mixture of isoflurane and oxygen (2.5%)/0.8 L/min.
ing to the manufacturer's protocol 1 day before transplantation. The day after, the adherent PKH-MSC (17.9 × The breathing rate of the rats was monitored during the experiment. For imaging the rats were carefully fixed in 10 6 ) were labeled with JPR (8.5 × 10 6 ); 9.4 × 10 6 MSC remained unlabeled. A total number of 4 × 10 6 cells per the animal bed and then positioned inside the magnet isocenter of the MRI System. Imaging was performed at animal were injected IV into rats on the day of immunization. Two rats received either unlabeled PKH26-posi-a 7.0 Tesla ClinScan in vivo animal MRI System (Bruker BioSpin MRI, Ettlingen, Germany). The system tive MSC or PKH26-positive JPR-MSC; two control rats were injected PBS IV. Rats were killed 9 days after im-operates at 300 MHz and is equipped with a 300-mm bore magnet and a 300 mT/m gradient system with an munization and transcardially perfused with PBS. Brains, spinal cords, lungs, livers, spleens, and lymphnodes inner diameter of 200 mm. The system utilizes the syngo MR software (Siemens, Erlangen, Germany) that was were dissected out. The tissue was immediately snapfrozen in liquid nitrogen. Cryosections (10 µm) of the used for data acquisition and processing.
Localizer scans in three planes were performed ini-tissue were postfixed in 4% paraformaldehyde, washed three times with PBS, and stained for iron as described were performed as follows. Four independent investiga-disease induction with MOG. No difference could be detected between the groups (Fig. 1B) . tors who were not involved into the prior investigations counted PKH-positive cells and DAPI-positive cells on H&E staining demonstrated typical inflammatory cuffing around blood vessels with cellular infiltration blinded fluorescence microphotographs of the respective organ. Quantification was done by calculating the per-into the CNS parenchyma ( Fig. 2A and B The cells showed adipogenic, osteogenic, and chonhancement. Dehydration was completed in propylene drogenic differentiation, indicating their stem cell plasoxide. The specimens were embedded in Araldite (Serva). ticity ( Figs. 3, 4, and 5 ). Compared to the sample treated Ultrathin sections were produced on a FCR Reichert with ostoegenic medium, the control cells (normal me-Ultracut ultramicrotome (Leica, Bensheim, Germany), dium) showed some spontaneous osteogenic differentiamounted on pioloform-coated copper grids, contrasted tion potential (Fig. 4) . JPR-MSC expressed lineagewith lead citrate, and analyzed and documented with an specific genes (LPL, PPARγ, ALP, COL2) after in vitro EM 10A electron microscope (Zeiss, Oberkochen, Gerdifferentiation ( Fig. 6) , indicating their plasticity. many). The electron microscopy procedure and revision
The clonal MSC were positive for CD29, CD44, of the images was performed by one author with exper-CD59, CD73, and CD90, expressed low CD71, CD117, tise in this field for decades. and MHC class I, and were negative for CD4, CD8, CD11b, CD31, CD45, CD106, CD143, and MHC class Statistics and Data Analysis II. The expression of c-kit (CD117) was slightly reduced Following assessment of normal distribution, statistion the JPR-MSC (18%) compared to the unlabeled MSC cal significance was tested by Student's t-test. In non-(31%). The expression of the other surface epitopes of normally distributed samples the Mann-Whitney U-test labeled and unlabeled MSC at passage 6 showed no difwas applied. Before transplantation the JPR-MSC showed a mean We assessed the influence of the treatment with MSC on EAE. Former reports have indicated a disease-protec-viability of 85.1%, and unlabeled MSC showed a mean viability of 89.7%. tive effect of MSC. DA rats developed full-blown MOG EAE starting on day 10 PI. Treatment with MSC re-MR Imaging sulted in disease amelioration. In contrast, treatment with MSC labeled with SPIO did not result in disease
The target organ of the hepatotrophic SPIO is the liver. Therefore, imaging focusing on the liver was per-amelioration compared to the control group treated with PBS alone (p < 0.05, ANOVA, each group n = 8, sum formed at a 7.0 Tesla ClinScan in vivo animal MRI System at days 2 and 8 after transplantation and EAE score) but aggravated the clinical symptoms (Fig. 1A) . This unexpected finding prompted us to further explore immunization. The iron content of the liver tissue correlates to the signal decrease in the MRI measurements. the effect of SPIO on disease course in EAE. We treated groups of rats with either SPIO or PBS on the day of Higher iron contents in the liver lead to hypointensive images compared to the control without additionally estingly, the hepatic iron content of the group receiving JPR-MSC (Fig. 7B ) was lower than in the Resovist iron, under the MR sequences used (Fig. 7) . The highest iron content could be detected in the group having re-group, although the administered overall iron dose was identical. Between the groups the hepatic iron content ceived Resovist alone (Fig. 7A) , and the lowest in the group having received unlabeled MSC (Fig. 7C) group and the JPR-MSC group the iron content in-no iron could be detected within the liver sinusoids of the animals treated with MSC ( Fig. 9B ). creased slightly (Fig. 8) .
Histological Evaluation of Hepatic Iron Content MSC and Localization of Iron Particles Before and After Transplantation At day 40 after transplantation iron could be detected by Prussian blue staining within the liver sinusoids of
Scanning electron microscopy before transplantation revealed that directly after the labeling procedure, the the animals treated with JPR-MSC (Fig. 9A) , whereas iron particles were localized on the surface of the planted JPR-MSC ( Fig. 11A-C) but could in part be detected in the brain tissue without any morpho-MSC covering the cells, whereas no iron particles had been transferred into the cells (Fig. 10 ). Nine days logical correlation to the transplanted JPR-MSC (Fig. 11D, E) . As expected, in the MSC-group no after transplantation, fluorescence microscopy and light microscopy of the brain showed that the iron par-iron particles could be detected in the brain (Fig.  11F ). ticles were no longer strictly associated to the trans-
Homing of JPR-MSC and MSC in Rats With EAE
Nine days after transplantation the homing pattern of the JPR-MSC and MSC was evaluated. Both groups showed similar preferences for target organs after systemic application. The JPR-MSC as well as the MSC were preferentially detected in the brain, cerebellum, spinal cord, and liver (means of percentages of PKH26positive cells from 25.49% to 38.91%), whereas in the lung, spleen, and lymph nodes only few cells could be detected (means of percentages of PKH26-positive cells from 5.27% to 11.31%) (Fig. 13) .
The homing pattern of the groups, however, partially differed in the respective organ. In the brain (means of percentage of PKH26-positive cells-JPR-MSC: 38.91% vs. MSC: 27.03%; p < 0.01) and in the spinal cord (means of percentage of PKH26-positive cells-JPR-MSC: 32.78% vs. MSC: 28.31%) more JPR-MSC than MSC could be detected ( Figs. 12 and 13 ). In the lymph nodes (means of percentage of PKH26-positive cells-JPR-MSC: 5.27% vs. MSC: 8.31%; p < 0.05) and in the liver (means of percentage of PKH26-positive cells-JPR-MSC: 25.49% vs. MSC: 29.02%) more MSC than JPR-MSC could be detected (Fig. 13 ). In the controls (PBS) no PKH26 signal could be detected.
DISCUSSION
There are several noninvasive tools for the diagnosis and the evaluation of disease course and for therapeutic interventions in EAE. Using "conventional" MRI, lesions of demyelination can be detected in T2 weighted sequences, in T1 weighted sequences, and especially in T1 weighted sequences after the administration of a Gd- can also be used as a measure of brain damage in MS Mucopolysaccharides are stained blue to bluish green (Alcian phages (43) , has been performed in MS patients (9) and can be used in an animal model to predict lesion severity the labeling procedure, we used a clinically approved SPIO for labeling. To date there are no clinically ap-and disease development of EAE (2) .
The immunomodulatory properties of stem cells sug-proved USPIO. SPIOs are inherently highly hepatotrophic because of the iron-phagocytotic capacity of the gests their application for the treatment of MS/EAE. Although successfully introduced into experimental mod-von Kupffer cells (35). In our study macrophage MRI was not performed because usually this technique re-els of MS/EAE (14, 52, 60) , the mechanisms of influencing the disease by stem cells are still not elucidated. MSC, quires the usage of USPIO with significantly lower hepatotrophy than SPIO. Others performed macrophage im-known to ameliorate T-cell action (16, 23, 25, 28, 45) , may have suppressed the invasion of macrophages and other aging in the CNS by MRI and sonography in Lewis rats suffering from EAE using SPIO (30) . In contrast to our inflammatory cells mediating host cells. In order to assess the interaction of MSC with the host in EAE we study, no cells were used for the treatment of the disease and the administration of SPIO had been performed in used labeled MSC and evaluated their homing profile as well the fate of the labeling agent.
advanced stages of EAE. In our study we used an established SPIO-labeling In order to diminish possible side effects caused by protocol for rat MSC including a TA to enhance the TIL ation. Furthermore, FACS analysis of the cellular surface epitope pattern of the JPR-MSC showed, except for (47) . This protocol has been shown to neither influence the cellular iron metabolism or the viability nor the dif-a slightly reduced expression of c-kit on the JPR-MSC, no differences compared to the unlabeled MSC. These ferentiation potential of rat MSC (47) . In our study, too, the labeling procedure did not show any toxic effects on observations indicate that our labeling procedure did not directly harm the MSC like the previous reported toxic-the MSC (we observed no alteration of the viability of the JPR-MSC compared to the MSC group). JPR-MSC ity of TA-treated cells (1) . It has been shown that labeling of MSC with iron particles that had been taken up expressed lineage-specific genes after in vitro differenti- into the cells may influence the cellular iron metabolism cumulated in the liver. It remains unclear whether this cerebro-hepatic shift of SPIO in vivo is mediated by (38, 47) . Therefore, we used a labeling protocol leading to the deposition of iron complexes to the cellular sur-simple transport with the blood stream or mediated by cellular means of transportation like macrophages. face (21) in order to avoid any influence on the stem cell metabolism but to maximize the imaging properties
Referring to the graft, the main difference between the groups were the iron particles that were attached to by enhancing the TIL (47, 51) . We conclude that altered stem cell biology as a main reason for the different clini-the JPR-MSC and hereby exposed to the host's immune system. Iron deficiency as well as iron-eliminating ther-cal courses and homing patterns is not likely.
Interestingly, the hepatic iron content of the group apy suppresses the symptoms or even avoids development of EAE (13, 39) . Free radicals participate in the having received JPR-MSC was lower compared to the Resovist-labeled group, although the administered pathogenesis of EAE and iron has been implicated as the catalyst leading to their formation (27). Therefore, overall iron dose was identical. These results show a difference in in vivo distribution patterns of cell-associ-iron plays a crucial role in the pathogenesis of EAE, a fact that has been known for years since experimental ated iron particles and free iron particles. In our in vivo MRI studies we could detect iron accumulation only in studies on inflammatory diseases of the CNS (26) . Narrowing the possible reasons for the different clini-the liver, whereas no significant iron signal in other organs was obtained, although the homing rate of JPR-cal courses and degrees of demyelination of the groups down to the iron deposition in the CNS, it is likely that MSC (detected by fluorescence microscopy) in extrahepatic organs like the CNS was not lower than in the the JPR-MSC acted as vectors. Due to their known capacity to migrate to the site of injury (51), JPR-MSC liver. According to our observations, a combination of two mechanisms is likely: the liver is one preferred tar-delivered the iron to the damaged tissue. There, the iron as a known adjuvant for inflammatory processes may get organ of the transplanted JPR-MSC and MSC. Thus, the JPR-MSC preferably delivered iron to the liver like have boosted the inflammation, leading to the observed aggravation of the symptoms of EAE. This hypothesis to the CNS. Moreover, we have shown that the iron particles detach from the JPR-MSC surface after transplan-is encouraged by two observations of the study. Firstly, the hepatic iron content of the JPR-MSC group was tation in vivo. Consequently, the hepatotrophic SPIO ac- lower than the hepatic iron content of the group having rapidly internalized into macrophages, avoiding a longlasting exposure to the host's immune system as it may received the same dose of SPIO alone. Secondly, the CNS has been shown to be one preferred target of the be hypothesized by the application of JPR-MSC. In addition, tracking of iron-labeled MSC has been performed stem cells after transplantation [even in animals not suffering from EAE (46) ]. Therefore, the nonhepatic accu-without known side effects related to the labeling of the cells in animals (18, 19, 54) , but the defects (photochemi-mulated iron in the JPR-MSC group is supposed to be delivered (by the JPR-MSC) to the CNS (where iron cal or balloon-induced lesions causing spinal cord or cerebellar injury) are basically different from the patho-consequently could be detected microscopically). The clinical and histological data of our study did not corre-genesis of EAE. In our study in the CNS more JPR-MSC than unla-late to the immunological parameters that had been evaluated. Thus, we propose an iron-induced pathomechan-beled MSC could be detected, whereas in the lymph nodes and the liver more unlabeled MSC could be de-ism in our EAE model that does not depend on the classical immunological response in EAE.
tected. These observations lead to the second complex of possible labeling effects: interactions of the JPR-MSC Iron particles have already been applied in patients to visualize inflammatory events in the CNS using macro-with host cells and/or tissue. It is likely that the different detection rates of JPR-MSC and MSC in several organs phage imaging. According to our knowledge, in these studies, no adverse effects of the application of no-cell-are the result of the labeling procedure. Whether and how in detail the complex interactions involved in the bound iron particles on the clinical course of MS have been observed (9) . The iron particles may have been homing process, the survival, proliferation, and para- 
